BridgeMD
New treatment option for Stuttering, Adult
Official title Dopamine and Sensorimotor Function in Stuttering
ClinicalTrials.gov ID: NCT07215884
What this study is testing
What is Aripiprazole 10 MG?
Aripiprazole 10 MG is an investigational medicine, given as an once-daily, being studied as a potential treatment for stuttering, adult.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- native speakers of American English
- for adults who stutter, presence of stuttering will be confirmed, with onset before age 6 years
- Normal hearing
- Ages of 18 to 65 years
- healthy adults without hearing-language difficulties
You likely can't join if
- self-reported speech-language-hearing difficulties other than stuttering
- self-reported neurological or psychological problems
- other medications (drugs that affect dopaminergic system and/or benzodiazepines)
The study team makes the final eligibility decision.
Where it's taking place
- San Francisco, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Francisco, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.